Stepan Co: Form 10-Q for the period ended Jun 30, 2010
Filed with the SEC on Jul 30, 2010 and accepted by EDGAR at Jul 30, 2010, 09:35 ET.
Management's discussion and analysis
As filed, 61,539 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following is management’s discussion and analysis of certain significant factors that have affected the Company’s financial condition and results of operations during the interim period included in the accompanying condensed consolidated financial statements.
Overview
The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:
- Surfactants – Surfactants, which accounted for 75 percent of consolidated net sales for the first half of 2010, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos, body washes, toothpastes and fabric softeners. Other applications include germicidal quaternary compounds, lubricating ingredients, emulsifiers (for spreading agricultural products), plastics and composites and biodiesel. Surfactants are manufactured at six North American sites (five in the U.S. and one in Canada), three European sites (United Kingdom, France and Germany) and three Latin American sites (Mexico, Brazil and Colombia). The Company holds a 50 percent ownership interest in two joint ventures, Stepan Philippines and TIORCO, LLC, that are excluded from surfactant segment operating results. The joint ventures are accounted for under the equity method.
- Polymers – Polymers, which accounted for 22 percent of consolidated net sales for the first half of 2010, include two primary product lines: polyols and phthalic anhydride. Polyols are used in the manufacture of laminate insulation board for the construction industry and are also sold to the appliance, flexible foam and coatings, adhesives, sealants and elastomers (C.A.S.E.) industries. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In the U.S., polymer product lines are manufactured at the Company’s Millsdale, Illinois, site. Polyols are also manufactured at the Company’s Wesseling (Cologne), Germany facility, as well as at its 80-percent owned joint venture in Nanjing, China (which is included in consolidated results).
- Specialty Products – Specialty products, which accounted for three percent of consolidated net sales for the first half of 2010, include flavors, emulsifiers and solubilizers used in the food and pharmaceutical industries. Specialty products are manufactured primarily at the Company’s Maywood, New Jersey, site.
First half sales volume for 2010 was seven percent ahead of 2009 first half volume. The Company’s largest segment, surfactants, reported four percent quarter-over-quarter and five percent year-over-year volume growth. The economic downturn had less of an impact on surfactant sales volume due to their use in laundry and personal care products, which are relatively recession-resistant. Polymers, which was the segment most severely affected by the economic downturn (polymer products are used in roofing insulation, construction materials, automotive and recreational vehicle applications), posted second quarter 2010 sales volume that exceeded second quarter 2009 volume by 16 percent, while sales volume for the first half of the year were up 19 percent over last year’s first half.
Deferred Compensation Plans
The accounting for the Company’s deferred compensation plans and investment assets related to the plans can cause period-to-period fluctuations in Company expenses and profits. For the second quarter of 2010, the Company recorded $3.4 million in total expense related to the Company’s deferred compensation plans compared to $4.6 million of expense for the same period of 2009. For the six months ended June 30, 2010, total expense related to the Company’s deferred compensation plans was $1.3 million compared to income of $0.6 million for the six months ended June 30, 2009. The pretax effect of all deferred compensation-related activities (which includes realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects were recorded are displayed below (see the ‘Corporate Expenses’ section of this management discussion and analysis for further details):
(Dollars in millions)
| (Income) Expense Three Months Ended June 30 2010 | 2009 | Six Months Ended June 30 2010 | 2009 | |
|---|---|---|---|---|
| Deferred Compensation (Administrative Expense) | $2.7 | $5.4 | $0.9 | $(0.1) |
| Investment Income (Other, net) | — | — | — | — |
| Realized and Unrealized (Gains) Losses on Investments (Other, net) | 0.7 | (0.8) | 0.4 | (0.5) |
| Net Pretax Income Effect | $3.4 | $4.6 | $1.3 | $(0.6) |
21
Effects of Foreign Currency Translation
The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e. because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). For the quarter ended June 30, 2010, the impact of foreign currency translation was negligible on Company profits. For the first half of 2010, the U.S. dollar was weaker against nearly all the foreign currencies, except the European euro, in the locations where the Company does business, when compared to the exchange rates for the first half of 2009. Consequently, reported net sales, expense and income amounts for 2010 were higher than they would have been had the foreign currency exchange rates remained constant with the rates for 2009. Below is a table that presents the effect that foreign currency translation had on the year-to-year changes in consolidated net sales and various income line items for the first half ending June 30, 2010:
(In millions)
| Six Months Ended June 30 2010 | 2009 | Increase | Increase Due to Foreign Translation | |
|---|---|---|---|---|
| Net Sales | $703.5 | $639.3 | $64.2 | $12.4 |
| Gross Profit | 127.0 | 114.4 | 12.6 | 2.2 |
| Operating Income | 63.4 | 57.4 | 6.0 | 1.7 |
| Pretax Income | 58.0 | 53.9 | 4.1 | 1.4 |
RESULTS OF OPERATIONS
Three Months Ended June 30, 2010 and 2009
Summary
Net income for the second quarter of 2010 declined 13 percent to $17.0 million, or $1.53 per diluted share, compared to $19.6 million, or $1.83 per diluted share, for the second quarter of 2009. Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the second quarter of 2010 follows the summary.
Consolidated net sales increased $45.3 million, or 14 percent, quarter over quarter. Higher average selling prices and sales volumes accounted for approximately $25.5 million and $19.9 million, respectively, of the net sales increase. The net effects of foreign currency translation were insignificant. The increase in average selling prices reflected higher raw material costs. Sales volumes increased six percent, reflecting improvements in the economy and successful execution of specific opportunities in core markets. Polymers and surfactants segments sales volumes were up 16 percent and four percent, respectively.
Operating income for the second quarter of 2010 declined $1.4 million, or five percent, from operating income for the second quarter of 2009. Gross profit decreased $2.2 million, or three percent. Surfactants segment gross profit was down $1.7 million, or four percent; polymers segment gross profit decreased $0.4 million, or three percent; and gross profit for the specialty products segment dropped $0.2 million, or four percent. The impact of higher raw material costs more than offset the effects of higher sales volume and average selling prices.
Operating expenses declined $0.8 million, or two percent, from quarter to quarter. Major items accounting for the expense increase were as follows:
(Dollars in millions)
| Increase (Decrease) | |
|---|---|
| Deferred Compensation Expense | $(2.7) |
| Bad Debt Expense | (1.1) |
| Salary Fringe Benefits | (0.5) |
| European Product Registration | 0.4 |
| Travel Expense | 0.5 |
| Consulting Expense | 0.8 |
| Salary Expense | 0.8 |
| Other | 1.0 |
| Total | $(0.8) |
The reduction in deferred compensation expense was attributable to changes in the values for the mutual fund assets and Company common stock to which the deferred compensation obligation is tied. See the ‘Overview’ and ‘Corporate Expenses’ sections of this management discussion and analysis for further details. Bad debt expenses declined as a result of lower reserve requirements, particularly for previously identified high-risk accounts. Salary fringe benefits were down quarter-over-quarter due primarily to lower bonus expense, which reflected higher performance targets. European product registration reflected higher expenses for registering the Company’s products under Europe’s Registration, Evaluation, Authorisation and Restriction of Chemical Substances (REACH) regulation. The increase in travel-related expenses was due to the unusually low expenses in the prior year that resulted from the Company’s restriction of travel implemented during the economic recession. Higher salary expense reflected increased personnel and normal pay raises. The increase in the number of employees was attributable to filling open positions and the addition of positions for the Company’s expanded efforts in Asia.
The loss from equity joint ventures, which includes results for the 50-percent owned SPI and TIORCO joint ventures, increased $0.5 million from quarter to quarter. Equity in SPI’s income fell $0.3 million between quarters and equity in TIORCO’s loss increased $0.2 million. The Company also sells surfactant products to TIORCO customers. The sales and resulting income from the sales are included in the Company’s surfactants segment operating results.
The other, net line item of the consolidated statement of income includes investment related income (i.e. dividends, interest and realized and unrealized gains and losses) associated with the Company’s mutual fund assets held for the deferred compensation plans and foreign exchange gains and losses. Other, net was $1.1 million of expense for the second quarter of 2010 compared to $1.3 million of income for the same period of 2009. Unfavorable swings of $1.5 million and $0.9 million in realized and unrealized gains and losses on investments and foreign exchange gains and losses, respectively, accounted for the $2.4 million quarter-over-quarter unfavorable other, net change.
The effective tax rate was 35.3 percent for the second quarter ended June 30, 2010, compared to 36.1 percent for the second quarter ended June 30, 2009. The decrease in the effective tax rate was primarily attributable to an increase in the domestic production activities deduction.
Segment Results
(Dollars in thousands)
| For the three months ended June 30, 2010 | Surfactants | Polymers | Specialty Products | Segment Results | Corporate | Total |
|---|---|---|---|---|---|---|
| Net sales | $264,567 | $90,893 | $11,044 | $366,504 | — | $366,504 |
| Operating income | 26,735 | 10,512 | 3,776 | 41,023 | (11,251) | 29,772 |
| For the three months ended June 30, 2009 | ||||||
| Net sales | $238,480 | $71,130 | $11,589 | $321,199 | — | $321,199 |
| Operating income | 29,174 | 11,133 | 3,976 | 44,283 | (13,095) | 31,188 |
Surfactants
Surfactants net sales for the second quarter of 2010 increased $26.1 million, or 11 percent, from net sales for the second quarter of 2009. Higher average selling prices, a four percent increase in sales volume and the effects of foreign currency translation accounted for approximately $14.3 million, $10.1 million and $1.7 million, respectively, of the net sales change. A quarter-to-quarter comparison of net sales by region follows:
(Dollars in thousands)
| For the Three Months Ended June 30, 2010 | June 30, 2009 | Increase | Percent Change | |
|---|---|---|---|---|
| North America | $179,221 | $162,088 | $17,133 | +11 |
| Europe | 58,478 | 51,410 | 7,068 | +14 |
| Latin America | 26,868 | 24,982 | 1,886 | +8 |
| Total Surfactants Segment | $264,567 | $238,480 | $26,087 | +11 |
24
Net sales for North American operations grew 11 percent due to a five percent increase in sales volume, a four percent increase in average selling prices and the effects of foreign currency translation, which accounted for $8.8 million, $6.1 million and $2.2 million, respectively, of the net sales change. Sales into all major market segments were up quarter over quarter due to the recovering economy and successful execution of specific opportunities in core markets. The higher average selling prices reflected increased costs for raw materials. The foreign currency translation effect resulted from the strengthening of the Canadian dollar against the U.S. dollar.
Net sales for European operations increased 14 percent due to higher average selling prices and a 10 percent increase in sales volume, which accounted for $5.2 million and $4.9 million, respectively, of the net sales increase. The unfavorable effects of foreign currency translation reduced the quarter-to-quarter change by $3.0 million. Average selling prices increased nine percent due largely to higher raw material costs. The foreign currency impact was caused by the quarter-over-quarter weakening of the European euro and the U.K. pound sterling against the U.S. dollar.
Net sales for Latin American operations increased eight percent due to the effects of foreign currency translation and higher average selling prices, which accounted for $2.4 million and $1.9 million, respectively, of the increase. A 10 percent decline in sales volume reduced the quarter-over-quarter change by $2.4 million. The favorable currency translation impact resulted from the strengthening of the currencies for all three Latin American locations against the U.S. dollar. Average selling prices for the second quarter of 2010 were eight percent higher than average prices for the same quarter of last year. A different product sales mix caused the increase in average selling prices. The sales volume decline reflected lower sales volume for the Company’s Brazil subsidiary due to a planned shutdown to facilitate a plant expansion to be completed later in 2010.
Surfactants operating income for the second quarter of 2010 declined $2.4 million, or eight percent, from operating income for the second quarter of last year. Despite the increase in sales volume, gross profit decreased $1.7 million due largely to the impact of higher raw material costs. Operating expenses increased $0.7 million, or four percent. Quarter-to-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:
(Dollars in thousands)
| Gross Profit | For the Three Months Ended June 30, 2010 | June 30, 2009 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $34,365 | $35,704 | $(1,339) | -4 |
| Europe | 5,535 | 7,170 | (1,635) | -23 |
| Latin America | 4,425 | 3,190 | 1,235 | +39 |
| Total Surfactants Segment | $44,325 | $46,064 | $(1,739) | -4 |
| Operating Expenses | 17,590 | 16,890 | 700 | +4 |
| Operating Income | $26,735 | $29,174 | $(2,439) | -8 |
25
Gross profit for North American operations declined four percent for the quarter due to higher manufacturing costs related to higher maintenance costs and increased headcount. Selling price increases have been largely effective in recovering recent raw material cost increases. Further price increases have been announced for the third quarter of 2010.
Gross profit for European operations declined 23 percent primarily as a result of higher raw material costs, which have more than offset the impacts of the previously noted selling price and sales volume increases. Due to competitive pressures, selling price increases have lagged behind the rising costs of raw materials. Also negatively affecting the quarter-to-quarter change in gross profit was $0.3 million for the negative effect of foreign currency translation.
Gross profit for Latin American operations improved 39 percent largely due to improved results for the region’s Mexico subsidiary. Higher margins drove Mexico’s profit improvement as the effects of higher selling prices and lower raw material costs more than offset the impact of lower sales volume for Latin American operations. A more favorable mix of sales for the region and $0.4 million from the favorable effects of foreign currency translation also contributed.
Operating expenses for the surfactants segment were up $0.7 million, or four percent, from quarter to quarter. The higher operating expenses were primarily due to $0.6 million and $0.4 million increases for European and Latin American operations, respectively, partially offset by a $0.2 million decline in expenses for North American operations. Increased expenses related to registering the Company’s products under Europe’s REACH regulation ($0.4 million) accounted for the higher European operations expenses, and increased marketing expenses ($0.3 million) accounted for the higher Latin American operations operating expenses. The quarter-over-quarter change for North American operations included a $0.9 million decrease in marketing expenses partially offset by a $0.7 million increase in research and development expenses. Decreases in bad debt expense ($1.2 million), due to reduced reserve requirements, accounted for the marketing expense decline. The increase in research and development expenses included numerous items, the largest of which was increased expense for contracted services and consulting ($0.4 million).
Polymers
Net sales for the second quarter of 2010 increased $19.8 million, or 28 percent, from net sales for the same quarter of 2009. A 16 percent increase in sales volume and a 10 percent increase in average selling prices accounted for $11.2 million and $10.4 million, respectively, of the increase in net sales. The effects of foreign currency translation reduced net sales by $1.8 million. A quarter-to-quarter comparison of net sales by region is displayed below:
(Dollars in thousands)
| For the Three Months Ended June 30, 2010 | June 30, 2009 | Increase | Percent Change | |
|---|---|---|---|---|
| North America | $61,611 | $50,929 | $10,682 | +21 |
| Europe | 23,803 | 16,916 | 6,887 | +41 |
| Asia and Other | 5,479 | 3,285 | 2,194 | +67 |
| Total Polymers Segment | $90,893 | $71,130 | $19,763 | +28 |
26
Net sales for North American operations increased 21 percent due to a 12 percent increase in average selling prices and an eight percent increase in sales volume. The higher average selling prices and sales volume led to $6.5 million and $4.2 million, respectively, of the increase in net sales. The increase in average selling prices reflected rising raw material costs. Sales volume for phthalic anhydride and polyols increased 10 percent and eight percent, respectively, due primarily to an improving economy.
Net sales for European operations increased 41 percent due to a 33 percent increase in sales volume and a 13 percent increase in average selling prices, which accounted for $5.6 million and $3.1 million, respectively, of the growth in net sales. The higher quarter-over-quarter sales volume reflected improved economic conditions. Higher raw material costs led to the increase in average selling prices. The effects of foreign currency translation reduced the impact of the higher sales volume and selling prices by $1.8 million.
Asia and Other operations’ net sales were up 67 percent from quarter to quarter due principally to increased sales volume for the Company’s China joint venture. Higher average selling prices also contributed.
Polymers operating income for the second quarter of 2010 declined $0.6 million from last year’s second quarter operating income. Gross profit declined $0.4 million, or three percent, due to lower unit margins for European operations. Below are quarter-to-quarter comparisons of gross profit by region and total segment operating expenses and operating income:
(Dollars in thousands)
| Gross Profit | For the Three Months Ended June 30, 2010 | June 30, 2009 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $11,833 | $10,956 | $877 | +8 |
| Europe | 2,789 | 4,315 | (1,526) | -35 |
| Asia and Other | 418 | 216 | 202 | +94 |
| Total Polymers Segment | $15,040 | $15,487 | $(447) | -3 |
| Operating Expenses | 4,528 | 4,354 | 174 | +4 |
| Operating Income | $10,512 | $11,133 | $(621) | -6 |
The eight percent increase in gross profit for North American operations was entirely due to the previously noted eight percent improvement in sales volume. Unit margins remained unchanged from quarter to quarter as the increase in average selling prices was offset by increases in raw material costs. Raw material costs have risen, placing downward pressure on margins particularly for the region’s polyol products. In a continued effort to stem profit erosion, the Company announced additional polyol selling price increases for the third quarter.
Gross profit for European operations declined 35 percent due to falling margins. The negative effects of rising raw material costs more than offset the impact of the 33 percent increase in sales volume. Selling prices have been raised but have not kept pace with the increases in the cost of raw materials. Price increases will continue to be made as the market allows.
The increase in gross profit for Asia and Other operations reflected higher sales volume for the Company’s China joint venture.
The $0.2 million increase in operating expenses was largely due to higher marketing expenses for North American operations.
Specialty Products
Net sales for the second quarter of 2010 were $0.5 million, or five percent, lower than net sales for the second quarter of 2009. Quarter-over-quarter operating income decreased $0.2 million. Lower sales volumes led to the net sales and operating income declines.
Corporate Expenses
Corporate expenses, which comprise expenses that are not allocated to the reportable segments, declined $1.8 million to $11.3 million for the second quarter of 2010 from $13.1 million for the second quarter of 2009. A $2.7 million decrease in deferred compensation expense accounted for the decline. The reduction in deferred compensation expense was attributable to changes in the values for the mutual fund assets and Company common stock to which the deferred compensation obligation is tied (the accounting for the deferred compensation plan results in income when the values of Company common stock or mutual funds held in the plan fall and expense when values rise). Specifically, the drop in deferred compensation expense reflected 1) a second quarter 2010 decline in the value of mutual fund assets compared to a second quarter 2009 increase in mutual fund value and 2) a smaller quarter-over-quarter increase in the value of Company common stock. The value of Company common stock increased $12.54 from $55.89 per share at March 31, 2010, to $68.43 per share at June 30, 2010. For last year’s second quarter, the Company’s common stock price increased $16.86 per share from $27.30 per share at March 31, 2009, to $44.16 per share at June 30, 2009. Higher quarter-over-quarter salary and consulting expenses partially offset the effect of the lower deferred compensation expense.
Six Months Ended June 30, 2010 and 2009
Summary
Net income for the first half of 2010 increased nine percent to $37.7 million, or $3.41 per diluted share, compared to $34.7 million, or $3.26 per diluted share, for the first half of 2009. All three reportable segments contributed to the favorable results. Below is a summary discussion of the major factors leading to the year-over-year changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first half of 2010 follows the summary.
Consolidated net sales for the first half of 2010 increased $64.2 million, or 10 percent, from net sales for the same period last year. Higher sales volume, the effects of foreign currency translation and higher average selling prices accounted for approximately $45.4 million, $12.4 million and $6.4 million, respectively, of the year-over-year increase in net sales. Sales volumes increased seven percent due to better economic conditions and successful execution of specific opportunities in core markets. All three segments reported increased sales volumes. Average selling prices increased due principally to rising raw material costs in the polymer segment
Operating income for the first half of 2010 was $6.1 million, or 11 percent, greater than operating income for the first half of 2009. Gross profit improved $12.7 million, or 11 percent. All three segments contributed to the improvement in gross profit. Surfactants segment gross profit was up $6.1 million, or seven percent; polymers segment gross profit increased $4.0 million, or 18 percent; and gross profit for the specialty products segment was up $2.3 million, or 32 percent. Higher sales volume benefited all segments. The effects of foreign currency translation contributed $2.2 million to the year-to-year consolidated gross profit improvement.
Operating expenses increased $6.6 million, or 12 percent, year over year. Major items accounting for the expense increase were as follows:
(Dollars in millions)
| Increase (Decrease) | |
|---|---|
| Salary Expense | $1.1 |
| Deferred Compensation Expense | 1.0 |
| Travel Expense | 1.0 |
| European Product Registration | 0.9 |
| Consulting Expense | 0.9 |
| Salary Fringe Benefits | 0.6 |
| Foreign Currency Translation | 0.6 |
| Bad Debt Expense | (0.9) |
| Other | 1.4 |
| Total | $6.6 |
The increase in salary expense reflected increased personnel and normal pay raises. The increase in the number of employees was attributable to filling open positions and the addition of positions to support the Company’s expanded efforts in Asia, as well as planned increased headcount to support the Company’s innovation projects with the research and development group. The Company recorded $0.9 million of deferred compensation expense for the first half of 2010 compared to $0.1 million of income for the same period of 2009 an unfavorable change of $1.0 million. The increase in the value of Company common stock, to which a large portion of the deferred compensation obligation is tied, accounted for the deferred compensation expense. See the ‘Overview’ and ‘Corporate Expenses’ sections of this management discussion and analysis for further details. The increase in travel-related expenses was due to the unusually low expenses in the prior year that resulted from the Company’s restriction of travel implemented during the economic recession coupled with significant travel related to the Company’s acquisition efforts in Poland and Singapore. European product registration reflected higher expenses for registering the Company’s products under Europe’s REACH regulation. The higher fringe benefit expenses reflected an increase in profit sharing expense, attributable to the improvement in Company earnings. The reduction in bad debt expenses was attributable to lower reserve requirements, particularly for previously identified high-risk accounts.
Interest expense for the first half of 2010 was $0.7 million, or 19 percent, less than interest expense for the first half of 2009. Lower average debt levels led to the decline. Average debt levels and interest expense will increase in future periods as the Company borrowed $40 million on June 1, 2010, in private placement notes. See the ‘Liquidity and Capital Resources’ section of this management discussion and analysis.
The loss from equity joint ventures, which includes results for the 50-percent owned SPI and TIORCO joint ventures, increased $0.2 million, or 22 percent, between years. The equity income in SPI increased $0.1 million from year to year, while the equity loss in TIORCO increased $0.3 million. The Company also sells surfactant products to TIORCO customers. The sales and resulting income from the sales are included in the Company’s surfactants segment operating results.
The other, net line item of the consolidated statement of income includes investment related income (i.e. dividends, interest and realized and unrealized gains and losses) associated with the Company’s mutual fund assets held for the deferred compensation plans and foreign exchange gains and losses. Other, net was expense of $1.3 million for the first half of 2010 compared to income of $1.0 million for the same period of 2009. Unfavorable swings of $1.5 million and $0.8 million for foreign exchange gains and losses and realized and unrealized gains and losses on investments, respectively, accounted for the $2.3 million year-over-year unfavorable other, net change.
The effective tax rate was 34.9 percent for the first six months ended June 30, 2010, compared to 35.6 percent for the first six months ended June 30, 2009. The decrease in the effective tax rate was primarily attributable to an increase in the domestic production activities deduction.
Segment Results
(Dollars in thousands)
| For the six months ended June 30, 2010 | Surfactants | Polymers | Specialty Products | Segment Results | Corporate | Total |
|---|---|---|---|---|---|---|
| Net sales | $526,880 | $154,003 | $22,651 | $703,534 | — | $703,534 |
| Operating income | 55,988 | 17,164 | 7,999 | 81,151 | (17,724) | 63,427 |
| For the six months ended June 30, 2009 | ||||||
| Net sales | $498,114 | $119,843 | $21,385 | $639,342 | — | $639,342 |
| Operating income | 53,360 | 13,736 | 5,639 | 72,735 | (15,378) | 57,357 |
30
Surfactants
Surfactants net sales for the first half of 2010 were $28.8 million, or six percent, greater than net sales for the first half of 2009. A five percent increase in sales volume and the effects of foreign currency translation accounted for approximately $24.7 million and $13.1 million, respectively, of the net sales change. Lower average selling prices, due largely to lower raw material costs, reduced the year-over-year change by $9.0 million. A year-to-year comparison of net sales by region follows:
(Dollars in thousands)
| For the Six Months Ended June 30, 2010 | June 30, 2009 | Increase | Percent Change | |
|---|---|---|---|---|
| North America | $357,841 | $337,524 | $20,317 | +6 |
| Europe | 118,058 | 110,446 | 7,612 | +7 |
| Latin America | 50,981 | 50,144 | 837 | +2 |
| Total Surfactants Segment | $526,880 | $498,114 | $28,766 | +6 |
Net sales for North American operations increased six percent due to a six percent increase in sales volume and the effects of foreign currency translation, which accounted for $21.2 million and $5.9 million, respectively, of the net sales change. A two percent decline in average selling prices reduced the year-over-year change by $6.8 million. Sales into all major market segments were up between years, reflecting recovery from the economic recession and successful execution of specific opportunities in core markets. The foreign currency translation effect resulted from the strengthening of the Canadian dollar against the U.S. dollar. The lower year-over-year average selling prices resulted from first quarter 2010 average prices that were seven percent lower than first quarter 2009 average prices. The first quarter selling price impact was partially offset by average selling prices for the second quarter of 2010 that were four percent greater than average prices for the second quarter of 2009. Selling prices rose in the second quarter of the current year due to higher raw material costs.
Net sales for European operations increased seven percent due to a four percent increase in sales volume, a two percent increase in average selling prices and the favorable effects of foreign currency translation, which accounted for $3.9 million, $2.8 million and $0.9 million, respectively, of the net sales change. Higher raw material costs caused the increase in average selling prices.
Net sales for Latin American operations increased two percent due to the effects of foreign currency translation (accounting for $6.2 million of the net sales change) partially offset by an 11 percent decline in average selling prices (a negative $5.5 million impact on the net sales change). The favorable currency translation impact resulted from the strengthening of the currencies for all three Latin American locations against the U.S. dollar. A different product sales mix contributed to the decline in average selling prices. Sales volume was essentially unchanged between years due to increases for the Company’s Brazil subsidiary offset by decreases for the Company’s Colombia and Mexico subsidiaries.
Surfactants operating income for the first quarter of 2010 was $2.6 million greater than operating income for the same period of 2009. Gross profit increased $6.1 million due primarily to a five percent increase in sales volume. The effects of foreign currency translation contributed $2.2 million of the favorable gross profit change. Operating expenses increased $3.5 million, or 11 percent. Year-to-year comparisons of gross profit by region and total segment operating expenses and operating income follow:
(Dollars in thousands)
| Gross Profit | For the Six Months Ended June 30, 2010 | June 30, 2009 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $71,603 | $62,901 | $8,702 | +14 |
| Europe | 12,602 | 16,050 | (3,448) | -21 |
| Latin America | 8,461 | 7,594 | 867 | +11 |
| Total Surfactants Segment | $92,666 | $86,545 | $6,121 | +7 |
| Operating Expenses | 36,678 | 33,185 | 3,493 | +11 |
| Operating Income | $55,988 | $53,360 | $2,628 | +5 |
Gross profit for North American operations increased 14 percent as a result of the previously noted six percent increase in sales volume and the effects of lower average year-over-year raw material costs. The impact of lower raw material costs occurred in the first quarter of 2010 when material costs remained lower than material costs for the same quarter of last year due to the economic recession that pressured raw material costs downward throughout most of 2009. Raw material costs actually increased in the second quarter of 2010, which led to 2010 second quarter gross profit declining $1.3 million from second quarter 2009 gross profit. Third quarter 2010 selling price increases have been announced to mitigate the effects of rising raw material costs on profit margins.
Gross profit for European operations declined 21 percent as a result of higher raw material costs, which more than offset the effects of the four percent increase in sales volume. Selling price increases have not kept pace with the rising costs of raw materials.
Gross profit for Latin American operations was up 11 percent due to the favorable effects of foreign currency translation, which accounted for $1.1 million of the year-to year gross profit change. The remainder of the change (i.e. a $0.2 million decline in gross profit) was primarily attributable to a change in sales mix.
Operating expenses for the surfactants segment were up $3.5 million, or 11 percent, between years. The increase was primarily due to increases of $1.3 million for both North American and European operations and a $0.6 million foreign currency translation effect. Expenses for North American operations increased as a result of higher research and development ($1.0 million) and marketing expenses ($0.3 million). Research expenses increased as the Company continues to commit more resources to its innovation projects to drive commercial success, resulting in higher salaries, travel and consulting expenses. Marketing expenses rose on higher salaries, travel and consulting as resources were increased to support the Company’s acquisition in Singapore and Asian growth plans. Favorable reductions in bad debt provisions partially offset the increases in marketing expense.
The $1.3 million increase in European operations expenses were principally attributable to expenses related to registering the Company’s products under Europe’s REACH regulation ($0.9 million). An increase in administrative expenses ($0.3 million), due largely to higher fringe benefit costs, also contributed.
Polymers
Polymers net sales for the first half of 2010 increased $34.2 million, or 29 percent, from net sales for the first half of 2009. A 19 percent increase in sales volume and higher average selling prices accounted for $23.1 million and $11.7 million, respectively, of the increase in net sales. The effects of foreign currency translation reduced the year-to-year change in net sales by $0.6 million. A year-to-year comparison of net sales by region is displayed below:
(Dollars in thousands)
| For the Six Months Ended June 30, 2010 | June 30, 2009 | Increase | Percent Change | |
|---|---|---|---|---|
| North America | $103,584 | $83,522 | $20,062 | +24 |
| Europe | 42,243 | 31,597 | 10,646 | +34 |
| Asia and Other | 8,176 | 4,724 | 3,452 | +73 |
| Total Polymers Segment | $154,003 | $119,843 | $34,160 | +29 |
Net sales for North American operations grew 24 percent due to a 14 percent increase in sales volume and a nine percent increase in average selling prices, which accounted for $11.4 million and $8.7 million, respectively, of the increase in net sales. Sales volume for phthalic anhydride and polyols increased 16 percent and 12 percent, respectively, which reflected improved economic conditions in the industries to which the polymer segment sells. Higher raw material costs led to the increase in average selling prices.
Net sales for European operations increased 34 percent due to a 29 percent increase in sales volume and a five percent increase in average selling prices. The increases in sales volume and average selling price accounted for $9.3 million and $2.0 million, respectively, of the net sales growth. Improved demand for polyol used in rigid insulation foam led to the improvement in sales volume. The increase in average selling prices was primarily attributable to higher raw material costs. The effects of foreign currency translation reduced the year-to-year net sales change by $0.7 million, which reflected the weakening of the European euro against the U.S. dollar. Asia and Other operations’ net sales were up 73 percent between years due largely to increased sales volume for the China joint venture.
Polymer operating income for the first half of 2010 increased $3.4 million, or 25 percent, from operating income for the same period of 2009. Gross profit increased $4.0 million, or 18 percent, due primarily to higher unit margins for North American operations and sales volume increases for all regions. Operating expenses increased $0.6 million, or seven percent, year over year. Below are year-to-year comparisons of gross profit by region and total segment operating expenses and operating income:
(Dollars in thousands)
| Gross Profit | For the Six Months Ended June 30, 2010 | June 30, 2009 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $19,275 | $13,771 | $5,504 | +40 |
| Europe | 6,208 | 8,050 | (1,842) | -23 |
| Asia and Other | 698 | 347 | 351 | +101 |
| Total Polymers Segment | $26,181 | $22,168 | $4,013 | +18 |
| Operating Expenses | 9,017 | 8,432 | 585 | +7 |
| Operating Income | $17,164 | $13,736 | $3,428 | +25 |
33
Gross profit for North American operations increased 40 percent, which accounted for the polymer segment’s overall improved profit. Higher quarter-over-quarter unit margins and sales volume led to the increase. Most of the improvement was attributable to the region’s phthalic anhydride product line, which reported negative margins for the first half of 2009. The unfavorable 2009 margins resulted from high priced material in inventory that was accumulated near the end of 2008 (and carried over into 2009) prior to the significant recession-driven decline in commodity costs. For the entire region, year-over-year margins were also favorably affected by manufacturing costs that remained unchanged from the prior year despite a 14 percent increase in sales volume. As the economy has begun to recover from the recession, raw material costs have risen, placing downward pressure on margins especially for polyol products. The Company has increased selling prices to recover those costs.
Gross profit for European operations declined 23 percent despite the 29 percent increase in sales volume. The effects of rising raw material costs more than offset the impact of higher sales volume. Selling prices have been raised but not yet enough to recover the higher costs. Price increases will continue to be made as the market allows.
The increase in gross profit for Asia and Other operations reflected higher sales volume.
The $0.6 million increase in operating expenses was principally attributable to higher marketing expenses for North American operations ($0.5 million). Acquisition related travel and high salary and bad debt expenses contributed to the North American marketing expense increase.
Specialty Products
Net sales for the first half of 2010 were $1.3 million, or six percent, higher than net sales for the first half of 2009. Higher sales volumes and a more favorable mix of sales led to the improvement. Operating income was up $2.4 million, or 42 percent, from year to year due to higher sales volumes, lower raw material costs and an improved sales mix resulting from increased sales of higher margin pharmaceutical products.
Corporate Expenses
Corporate expenses increased $2.3 million, or 15 percent, to $17.7 million for the first half of 2010 from $15.4 million for the first half of 2009. Deferred compensation expense accounted for $1.1 million of the increase, as the Company recorded $0.9 million of deferred compensation expense for the first half of 2010 compared to $0.1 million of income for the same period of 2009. The increase in the value of Company common stock, to which a large portion of the deferred compensation obligation is tied, accounted for the deferred compensation expense. The value of Company common stock was $68.43 per share at June 30, 2010, compared to $64.81 per share at December 31, 2009, an increase of $3.62 per share. For the first half of 2009, the Company’s common stock price declined $2.83 per share from $46.99 per share at December 31, 2008, to $44.16 per share at June 30, 2009. A first half 2010 decline in the value of the mutual fund assets held to partially fund the deferred compensation obligation versus an increase in the mutual fund values for the first half of 2009 led to deferred compensation income that partially offset the effect of the increase in the Company’s common stock price. A $0.4 million increase in salary expense also contributed to the year-over-year corporate expense increase. The remainder of the corporate expense increase resulted primarily from acquisition related travel and consulting expenses.
LIQUIDITY AND CAPITAL RESOURCES
For the first six months of 2010, cash flow from operating activities of $13.0 million plus debt sources of $41.0 million were used to fund investing cash outflows of $28.9 million and non-debt financing outflows of $5.0 million. As a result, cash increased by $19.3 million since last year-end, including $0.8 million of negative foreign exchange impact. Net income for the current year period was up by $3.0 million compared to the same period in 2009. However, cash flow from operating activities for the first half of 2010 was down by $73.0 million from a source of $86.0 million for the comparable period in 2009 mainly due to higher current year working capital requirements.
For the first six months of 2010, working capital was a use of $48.6 million versus a source of $24.4 million for the same period in 2009. For the current year period, accounts receivable were a cash use of $61.7 million compared to a cash source of $20.9 million for the first half of 2009. Inventories were a cash use of $13.7 million for the first six months of 2010 versus a cash source of $27.2 million for the comparable period in 2009. Accounts payable and accrued liabilities were a source of $27.8 million for the current year period compared to a use of $23.1 million for the comparable period last year.
The working capital increase during 2010 has been driven by higher sales volumes versus the fourth quarter of 2009 as well as by increased raw material costs and selling prices to customers during 2010. During 2009, in contrast, the Company had experienced lower raw material costs and lower sales versus the prior year fourth quarter, resulting in lower accounts receivable and lower inventories. The Company’s raw material costs are heavily influenced by the costs of crude oil-derived commodity chemicals, which are used by the Company as raw materials. Raw materials are a primary driver to the Company’s working capital, with a direct impact on inventory carrying costs as well as an indirect impact on accounts receivable via selling prices, both of which have increased during the first six months of 2010. The Company has not experienced a significant change in the payment timing of its receivables and has not changed its own payment practices related to its payables. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital during 2010.
Investing activities for the first half of 2010 were a net use of $28.9 million versus $12.0 million for the comparable period in 2009. For the current year period, capital expenditures have totaled $28.0 million, an increase of $4.6 million over $23.4 million for the first half of 2009. During 2010, the Company liquidated $0.7 million of investments for participant payouts versus $4.4 million in 2009. Also during 2009, the Company recovered $8.5 million of restricted cash relating to a 2008 Internal Revenue like-kind exchange, a singular cash inflow accountable for most of the period-to-period difference in net investing cash flows. For 2010, the Company estimates that full-year capital expenditures will be in a range of $75 million to $80 million, including capacity expansions in Germany and Brazil.
The Company purchases treasury shares in the open market from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may also make open market repurchases as cash flows permit when, in management’s opinion, the Company’s shares are undervalued in the market. For the first six months of 2010, the Company purchased 72,845 common shares for the treasury in the open market at a total cost of $3.8 million. As of June 30, 2010, there were 305,099 shares remaining under the current share repurchase authorization.
As of June 30, 2010, the Company’s cash and cash equivalents totaled $117.8 million, including $69.2 million in two separate U.S. money market funds, each of which was rated AAA by Standard and Poor’s and Aaa by Moody’s. Cash in U.S. demand deposit accounts totaled $21.6 million and cash of the Company’s non-U.S. subsidiaries held outside the U.S. totaled $27.0 million as of June 30, 2010.
Consolidated debt increased by $45.6 million during the first six months of 2010, from $104.1 million to $149.7 million, mainly due to a new $40.0 million private placement loan completed in June 2010. Since last year end, net debt, which is total debt minus cash, increased by $26.3 million, from $5.6 million to $31.9 million, reflecting a cash increase of $19.3 million. At June 30, 2010, the ratio of total debt to total debt plus shareholders’ equity was 32.1 percent, compared to 26.4 percent as of December 31, 2009. The ratio of net debt to net debt plus shareholders’ equity was 9.2 percent at June 30, 2010, compared to 1.9 percent at December 31, 2009.
As of June 30, 2010, the Company’s debt included $113.9 million of unsecured private placement loans with maturities extending from 2010 through 2022. These loans are the Company’s primary source of long-term debt financing, and are supplemented by bank credit facilities to meet short and medium term needs. The Company’s debt also included a $27.0 million term loan with its U.S. banks, which has remaining maturities from 2011 through 2013.
On June 1, 2010, the Company completed a new $40.0 million private placement loan with three insurance companies, with loan proceeds to be used for capital expenditures and other corporate purposes. This new loan bears fixed interest at 5.88 percent per annum payable semi-annually with equal annual principal repayments from 2016 through final maturity in 2022. Terms and conditions of this agreement are substantially the same as those in the agreement covering the Company’s 5.69 percent notes issued in 2005.
The Company currently has $58.3 million of credit available under its committed $60.0 million U.S. revolving credit agreement, which will require renewal on or before April 20, 2011. The Company is in discussion with its U.S. banks and expects to replace this agreement during the third quarter of 2010 with a new, committed $60 million revolving agreement. The new agreement is expected to have current market pricing with other terms and conditions similar to those in the present agreement. The Company anticipates that cash from operations and cash on hand, as well as committed credit facilities, will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.
Certain foreign subsidiaries of the Company maintain term loans and short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. As of June 30, 2010, the Company’s European subsidiaries had short-term bank debt of $3.6 million with available borrowing capacity of approximately $23.3 million. As of that date, Company’s Latin American subsidiaries had no debt with $5.9 million of available borrowing capacity. The Company’s 80 percent owned China joint venture had $0.4 million of short-term bank debt with $7.5 million in available borrowing capacity.
Included in the Company’s debt at June 30, 2010, was a $4.8 million obligation related to a build-to-suit lease agreement for the construction of a warehouse at the Company’s Millsdale (Joliet), Illinois, manufacturing site. The agreement was entered into in January 2010 and completion of the warehouse is scheduled for the fourth quarter of 2010.
The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. Testing for these agreements is based on the combined financial statements of the U.S. operations of Stepan Company and Stepan Canada Inc. (the “Restricted Group”). Under the most restrictive of these debt covenants:
1. The Restricted Group must maintain a minimum interest coverage ratio, as defined within the agreements, of 2.0 to 1.0, for the preceding four calendar quarters.
2. The Restricted Group must maintain net worth of at least $113.7 million.
3. The Restricted Group must maintain a ratio of long-term debt to total capitalization, as defined in the agreements, not to exceed 55 percent.
4. The Restricted Group may pay dividends and purchase treasury shares in amounts of up to $30.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively beginning December 31, 2001. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings on the Company’s balance sheet.
The Company was in compliance with all of its loan agreements as of June 30, 2010. Based on current projections, the Company believes it will be in compliance with its loan agreements throughout 2010.
ENVIRONMENTAL AND LEGAL MATTERS
The Company is subject to extensive federal, state and local environmental laws and regulations. Although the Company’s environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation could require the Company to make additional unforeseen environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first six months of 2010, the Company’s expenditures for capital projects related to the environment were $0.4 million. These projects are capitalized and depreciated over their estimated useful lives, which is typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were approximately $7.8 million and $7.4 million for the six months ended June 30, 2010 and 2009, respectively. While difficult to project, it is not anticipated that these recurring expenses will increase significantly in the future.
Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. Because reported liabilities are recorded based on estimates, actual amounts could differ from those estimates. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses from $7.2 million to $31.1 million at June 30, 2010, compared to $7.8 million to $31.9 million at December 31, 2009. At June 30, 2010, the Company’s accrued liability for such losses, which represents the Company’s best estimate within the estimated range of possible environmental and legal losses, was $16.3 million, compared to $17.1 million at December 31, 2009. During the first six months of 2010 and 2009, cash outlays related to legal and environmental matters approximated $1.6 million.
For certain sites, estimates cannot be made of the total costs of compliance or the Company’s share of such costs; consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Management believes that in the event of one or more adverse determinations in any annual or interim period, the impact on the Company’s cash flows and results of operations for those periods could be material. However, based upon the Company’s present belief as to its relative involvement at these sites, other viable entities’ responsibilities for cleanup and the extended period over which any costs would be incurred, the Company believes that these matters will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the Securities and Exchange Commission, which are available upon request from the Company. See also Note 7 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.
ACQUISITIONS
The following transactions were entered into subsequent to the June 30, 2010, reporting period of the financial statements included in this Form 10-Q:
On July 2, 2010, the Company purchased the manufacturing assets of Peter Cremer GmbH’s 100,000 ton per year methyl esters plant located on Jurong Island in Singapore. The Company plans to install methyl esters fractionation capability on the site. Methyl esters are a core building block of the Company’s surfactants segment, and the acquisition of the Jurong Island manufacturing assets provides the Company an opportunity to reach its global customer base with methyl esters and value added derivatives made from tropical oils available in the region. The Company plans for the site to begin methyl esters production by the end of 2011. The purchase price of the manufacturing assets was $10.4 million, which the Company paid from available cash.
On July 15, 2010, the Company’s Stepan Europe subsidiary acquired all the shares of Alfa Systems Sp, z o.o. (Alfa Systems). The purchase included a plant in Brzeg Dolny, Poland, which specializes in the manufacture of aromatic polyester polyol from recycled polyethylene terephthalate. Polyester polyols are the critical component of the Company’s polymers segment. The acquisition of Alfa Systems provides the Company manufacturing capability in Eastern Europe and the ability to economically and effectively serve customers in Central and Eastern Europe. The purchase price of the acquisition was approximately €9.1 million ($11.6 million), potentially reduced by €2.5 million for environmental remediation costs assumed by the Company and other possible claims that were unknown at the time of acquisition. The acquisition was financed using local (France) bank debt.
On July 19, 2010, the Company purchased controlling interest of the Stepan Philippines Inc. (SPI) joint venture, raising the Company’s ownership interest in the venture from 50 percent to 88.8 percent. In July, the Company paid $3.7 million of cash paid to purchase the interests of one owner, transferred $2.0 million of cash to SPI as an additional capital investment and capitalized a $3.9 million liability originally due the Company pursuant to a royalty agreement between the Company and SPI.
The Company does not believe the foregoing acquisitions will have a significant near-term effect on earnings, but will support the Company’s longer term global growth strategy.
OUTLOOK
The Company’s net income for the first half of 2010 was up nine percent over a strong 2009 first half. The decline in second quarter results was due to pressure on margins in Europe combined with higher expenses to support growth initiatives through acquisitions and increased research within the Company’s innovation portfolio. Price increases were implemented in the third quarter in an attempt to recover recent raw material cost increases.
Leveraging a strong balance sheet, the Company has made recent investments in Singapore, Poland and the Philippines to deliver long term growth for the Company. The Company’s strong first half volume gains were generated by improved market demand, market share gains and greater penetration of new end use markets. The Company expects these opportunities for growth will continue for the balance of this year and into 2011.
CRITICAL ACCOUNTING POLICIES
There have been no changes to the critical accounting policies disclosed in the Company’s 2009 Annual Report on Form 10-K.
OTHER
Except for the historical information contained herein, the matters discussed in this document are forward looking statements that involve risks and uncertainties. The results achieved this quarter are not necessarily an indication of future prospects for the Company. Actual results in future quarters may differ materially. Potential risks and uncertainties include, among others, fluctuations in the volume and timing of product orders, changes in demand for the Company’s products, the ability to pass on raw material price increases, changes in technology, continued competitive pressures in the marketplace, outcome of environmental contingencies, availability of raw materials, foreign currency fluctuations and the general economic conditions.
Controls and procedures
As filed, 728 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
a. Evaluation of Disclosure Controls and Procedures
Based on their evaluation of our disclosure controls and procedures as of the end of the most recent fiscal quarter covered by this Form 10-Q, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934) were effective as of June 30, 2010.
b. Changes in Internal Control Over Financial Reporting
There were no changes in internal controls that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Source: SEC EDGAR, the filing index for accession 0001193125-10-171622. Last ingested by Listed: Nov 10, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.